Doctor Thyroid

What Happens When Thyroid Cancer Travels to the Lungs? Fabian Pitoia, M.D., serves as the Head of the Thyroid Section of the Division of Endocrinology and Investigation Area Coordinator at the Hospital de Clinicas of the University of Buenos Aires (UBA). He works also as an Proffessor of internal medicine at the Faculty of Medicine (UBA). Dr Pitoia serves as a Full Member of the Argentine Society of Endocrinology and Metabolism, of the Latin American Thyroid Society, the Endocrine Society and he is a Correspondent Member of the American Thyroid Association. In this episode Dr. Pitoia addresses the following topics: 10% of thyroid cancer patients will have distant metastatic disease The disease will travel to lungs, bones, or both Treatment with RAI is most effective for those under 40 years old Evaluation of metastatic thyroid cancer in the lungs is a CT scan In 2006, there was a change in the treatment of the disease Adverse events of medication The coordination between the endocrinologist and the oncologist  RESOURCES ResearchGate Dr. Pitoia - Facebook Dr. Pitoia - web site Dr. Pitoia - Twitter Thyroid Cancer Alliance American Thyroid Association Hospital de Clínicas de la Universidad de Buenos Aires - Ciudad Autónoma de Buenos Aires.  Consultorio privado: Pte. J.E. Uriburu 754 - Piso 2. Teléfonos: 49545488/49525496  fpitoia@glandulatiroides.com.ar

12 Mai 201731min

Bienvenido al episodio 33 de Doctor Thyroid con Philip James.    El invitado de hoy es Dr. Fabian Pitoia.  El Dr. Pitoia es un experto endocrino mundial, que aparece en muchas publicaciones y conferencias mundiales, donde habla de cáncer de tiroides. El Dr Pitoia es médico endocrinólogo, está encargado de la Sección Tiroides de la División Endocrinología del Hospital de Clínicas de la Universidad de Buenos Aires. En este episodio, el Dr. Pitoia responde las siguientes preguntas: ¿Qué es la enfermedad metastásica en relación con el cáncer de tiroides?   Hay una tendencia de este enfermedad? ¿cómo se descubre la enfermedad metastásica? cuando se trata de cáncer de tiroides es un procedimiento típico para los médicos para detectar la enfermedad metastásica? si un paciente no responde a RAI (radioactiva), ¿qué es una opción de tratamiento? ¿Podemos hacer vigilancia activa cuando hay metástasis en los pulmones, ¿es lo mismo que el cáncer de pulmón? 600 milicurios de RAI .... ¿Hay peligro para este alto de una dosis? ¿hay efectos secundarios o peligros a los medicamentos usados ​​para tratar la enfermedad metastásica que no responde a la radiación? se le informa a un paciente de la enfermedad metastásica, y este es un área de estrés para los pacientes con cáncer de tiroides, ¿puede decirle a un paciente algo para reducir la ansiedad relacionada con la enfermedad metastásica? si un paciente tiene enfermedad metastásica, ¿es necesario un médico especial para el tratamiento? ¿cómo sabemos si un médico se especializa en la enfermedad metastásica? ¿hay una página web o recursos adicionales para aprender más sobre la enfermedad metastásica? Recursos: Dr. Pitoia - Facebook Dr. Pitoia - pagina web Dr. Pitoia - Twitter ResearchGate Thyroid Cancer Alliance American Thyroid Association - Español Hospital de Clínicas de la Universidad de Buenos Aires - Ciudad Autónoma de Buenos Aires.  Consultorio privado: Pte. J.E. Uriburu 754 - Piso 2. Teléfonos: 49545488/49525496  fpitoia@glandulatiroides.com.ar

12 Mai 201721min

El término nódulo tiroideo se refiere a cualquier crecimiento anormal de las células tiroideas formando un tumor dentro de la tiroides. Aunque la gran mayoría de los nódulos tiroideos son benignos (no cancerosos), una pequeña proporción de estos nódulos sí contienen cáncer de tiroides. Es por esta posibilidad que la evaluación de un nódulo tiroideo está dirigida a descubrir un potencial cáncer de tiroides. En esta entrevista, el Dr. Castro explica los siguientes temas: ¿Qué es un nódulo tiroideo? ¿Cuáles son los síntomas de un nódulo tiroideo? ¿Cómo se diagnostica el nódulo tiroideo? Punción de la tiroides con aguja fina Ecografía de la tiroides ¿Cómo se tratan los nódulos de la tiroides? Cuando la observación activa es la opción de tratamiento en lugar de una tiroidectomía Niños con nódulos tiroideos M. Regina Castro, MD es consultante en la División de Endocrinología de la Clínica Mayo de Rochester, MN. Es Profesora Asociada de Medicina. Es Directora Asociada del Programa de entrenamiento en la especialidad de Endocrinología, y Directora de la rotación de Endocrinología para la Residencia de Medicina Interna. También es miembro del Grupo de Tiroides de la Clínica Mayo. Ella sirvió de 2009 a 2015 como Editor de Sección de la Tiroides para el Programa de Autoevaluación de AACE y ha sido autora de varios capítulos sobre Hipertiroidismo, Nódulos de Tiroides y cáncer Notas Nódulos Tiroideos Regina Castro Publications American Thyroid Association en Español

4 Mai 201742min

In this episode Dr. Bernet describes that Hashimoto’s thyroiditis is an autoimmune condition that usually progresses slowly and often leads to low thyroid hormone levels — a condition called hypothyroidism. The best therapy for Hashimoto’s thyroiditis is to normalize thyroid hormone levels with medication. A balanced diet and other healthy lifestyle choices may help when you have Hashimoto’s, but a specific diet alone is unlikely to reverse the changes caused by the disease. Hashimoto’s thyroiditis develops when your body’s immune system mistakenly attacks your thyroid. It’s not clear why this happens. Some research seems to indicate that a virus or bacterium might trigger the immune response. It’s possible that a genetic predisposition also may be involved in the development of this autoimmune disorder. A chronic condition that develops over time, Hashimoto’s thyroiditis damages the thyroid and eventually can cause hypothyroidism. That means your thyroid no longer produces enough of the hormones it usually makes. If that happens, it can lead to symptoms such as fatigue, sluggishness, constipation, unexplained weight gain, increased sensitivity to cold, joint pain or stiffness, and muscle weakness. If you have symptoms of hypothyroidism, the most effective way to control them is to take a hormone replacement. That typically involves daily use of a synthetic thyroid hormone called levothyroxine that you take as an oral medication. It is identical to thyroxine, the natural version of a hormone made by your thyroid gland. The medication restores your hormone levels to normal and eliminates hypothyroidism symptoms. You may hear about products that contain a form of thyroid hormones derived from animals. They often are marketed as being natural. Because they are from animals, however, they aren’t natural to the human body, and they potentially can cause health problems. The American Thyroid Association’s hypothyroidism guidelines recommend against using these products as a first-line treatment for hypothyroidism. Although hormone replacement therapy is effective at controlling symptoms of Hashimoto’s thyroiditis, it is not a cure. You need to keep taking the medication to keep symptoms at bay. Treatment is usually lifelong. To make sure you get the right amount of hormone replacement for your body, you must have your hormone levels checked with a blood test once or twice a year. If symptoms linger despite hormone replacement therapy, you may need to have the dose of medication you take each day adjusted. If symptoms persist despite evidence of adequate hormone replacement therapy, it’s possible those symptoms could be a result of something other than Hashimoto’s thyroiditis. Talk to your health care provider about any bothersome symptoms you have while taking hormone replacement therapy. Victor J. Bernet, MD, is Chair of the Endocrinology Division at the Mayo Clinic in Jacksonville, Florida and is an Associate Professor in the Mayo Clinic College of Medicine. Dr. Bernet served 21+ years in the Army Medical Corps retiring as a Colonel. He served as Consultant in Endocrinology to the Army Surgeon General, Program Director for the National Capitol Consortium Endocrinology Fellowship and as an Associate Professor of Medicine at the Uniformed Services University of Health Sciences. Dr. Bernet has received numerous military awards, was awarded the “A” Proficiency Designator for professional excellence by the Army Surgeon General and the Peter Forsham Award for Academic Excellence by the Tri-Service Endocrine Society. Dr. Bernet graduated from the Virginia Military Institute and the University of Virginia School of Medicine. Dr. Bernet completed residency at Tripler Army Medical Center and his endocrinology fellowship at Walter Reed Army Medical Center. Dr. Bernet’s research interests include: improved diagnostics for thyroid cancer, thyroidectomy related hypocalcemia, thyroid hormone content within supplements as well as management of patient’s with thyroid cancer. He is the current Secretary and CEO of the American Thyroid Association.

22 Apr 201735min

This episode is a thorough presentation of Graves' Disease from Kimberly Dorris, an educator and expert, and also a patient.  In this episode, listeners will gain a thorough understanding of a disease that is often confused with other diagnosis.   Kimberly Dorris is the Executive Director and CEO of the Graves' Disease and Thyroid Foundation, a small nonprofit organization based in Rancho Santa Fe, CA. She began working with the GDATF as a volunteer in 2010, and took over day-to-day management of the Foundation in 2011.   ​Her responsibilities include organizing patient education events in various locations throughout the U.S.A., managing the Foundation's social media sites, producing print and electronic communications, seeking grant funding, and providing support for patients via phone, e-mail, and an online support forum.  ​ ​She also leads a monthly patient support group meeting in Phoenix, AZ.   ​Ms. Dorris has a unique perspective on thyroid dysfunction, having lived with both hyperthyroidism and hypothyroidism.  She was diagnosed with Graves' disease in 2007 and took methimazole for seven years.   ​A​pproximately 18 months after stopping the methimazole, she became hypothyroid and is currently taking replacement hormone.  ​   Ms. Dorris received a B.A. from the University of Arizona in 1990 and an M.B.A. from Belmont University in Nashville in 1990.  ​P​rior to joining the GDATF, she spent  ​8 years with Mercury Nashville Records, a year with KPMG Consulting, and ​ 10 years with a community bank, including a two-year term as chairman of the company’s Charitable Giving Committee.   NOTES & RESOURCES: GDATFWebsite:  http://gdatf.org/ GDATF Online Support Forum: http://gdatf.org/forum/ Reading List: http://gdatf.org/about/about-graves-disease/reading-list-for-patients/  Recommended Links: http://gdatf.org/about/about-graves-disease/links/ GDATF YouTube Site (includes free videos on Graves' disease, autoimmunity, and thyroid eye disease): https://www.youtube.com/user/GravesAndThyroid   Facebook: https://www.facebook.com/gdatf   Twitter: @GDATF   Patients and family members can also e-mail the Graves' Disease Foundation at info@gdatf.org or call toll-free 877-643-3123.

18 Apr 201726min

En este episodio explora los siguientes temas: Opciones de tratamiento para la enfermedad de Graves. Opciones de tratamiento para el hipertiroidismo. Peligros de la medicación del hyperthyroidism. Síntomas del hipertiroidismo. Dr. Alejandro Ayala obtuvo su doctorado de la Universidad Federal Fluminense en Río de Janeiro, Brasil, en 1992, y completó su residencia en medicina interna en la Universidad Federal de Sao Paulo. Posteriormente se unió al Programa de Medicina Interna de la Universidad de Georgetown en el Centro Hospitalario de Washington, donde recibió el Premio Saul Zukerman, MD, Humanitarianism in Medicine. El Dr. Ayala obtuvo su formación clínica en Endocrinología en el Hospital Universitario Johns Hopkins, seguido de una beca de investigación en los Institutos Nacionales de Salud (NIH) en Bethesda, Maryland, donde continuó durante los siguientes cinco años como clínico del personal, investigador clínico y facultad de El programa de entrenamiento de endocrinología NIH. Durante este tiempo, los intereses de investigación del Dr. Ayala están relacionados con los trastornos de la Neruendocrinología, la pituitaria y la adrenal. Sus intereses de investigación incluyen hiperaldosteronismo, síndrome de Cushing y feocromocitoma, áreas en las que ha sido autor de más de dos docenas de artículos revisados ​​por pares y ha escrito varios capítulos de libros. NOTAS: The Hormone Foundation Dr. Alejandro Ayala GDATFWebsite:  http://gdatf.org/   GDATF Online Support Forum: http://gdatf.org/forum/   Reading List: http://gdatf.org/about/about-graves-disease/reading-list-for-patients/   Recommended Links: http://gdatf.org/about/about-graves-disease/links/   GDATF YouTube Site (includes free videos on Graves' disease, autoimmunity, and thyroid eye disease): https://www.youtube.com/user/GravesAndThyroid   Facebook: https://www.facebook.com/gdatf   Twitter: @GDATF

18 Apr 201728min

In this interview, Dr. Hennessey describes the history, refinements, implementation, physiology, and clinical outcomes achieved over the past several centuries of thyroid hormone replacement strategies. Topics discussed in this episode include: The history of levothyroxin Chinese using thyroid hormone to treat cretinism in the 6th century What is cretinism? Dangers of hypothyroidism during pregnancy Prescribed 3-step process when hypothyroidism is treated when pregnant The history of sheep thyroid as a treatment? In the 1920’s thyroid hormone was synthesized T3 was synthesized in the 1950’s When to take thyroid medication, morning or night? A rich history of physician intervention in thyroid dysfunction was identified dating back more than 2 millennia. Although not precisely documented, thyroid ingestion from animal sources had been used for centuries but was finally scientifically described and documented in Europe over 130 years ago. Since the reports by Bettencourt and Murray, there has been a continuous documentation of outcomes, refinement of hormone preparation production, and updating of recommendations for the most effective and safe use of these hormones for relieving the symptoms of hypothyroidism. As the thyroid extract preparations contain both levothyroxine (LT4) and liothyronine (LT3), current guidelines do not endorse their use as controlled studies do not clearly document enhanced objective outcomes compared with LT4 monotherapy. Among current issues cited, the optimum ratio of LT4 to LT3 has yet to be determined, and the U.S. Food and Drug Administration (FDA) does not appear to be monitoring the thyroid hormone ratios or content in extract preparations on the market. Taken together, these limitations are important detriments to the use of thyroid extract products. James V. Hennessey, MD is Director of Clinical Endocrinology at Beth Israel Deaconess Medical Center in Boston, MA. He is an Associate Professor of Medicine at the Harvard medical School.  He completed medical training at the Medical Faculty of the Karl Franzens University in Graz Austria. He served as an Intern and Medical Resident at the New Britain Hospital in Connecticut. He entered active duty with the USAF Medical Corps as an Internist/Flight Surgeon after residency and later completed subspecialty training in endocrinology and metabolism at the Walter Reed Army Medical Center in Washington DC where he conducted research in thyroxine bioequivalence. Following fellowship Dr. Hennessey served as the Chief of Endocrinology at USAF Medical Center Wright-Patterson in Ohio and later joined the faculty at Wright State University School of Medicine as the Director of Clinical Clerkships. Top 10 most prescribes drugs in the U.S. (monthly) - Monthly prescriptions, nearly 22 million

14 Apr 201731min

¿Cómo sabemos si usted tiene hipotiroidismo? ¿Qué significa si es difícil concentrarse o enfocar la mente? ¿Qué significa si usted tiene altos niveles de TSH? ¿Cómo se diagnostica el hipotiroidismo? ¿Qué es Hashimotos? ¿Cuál es el tratamiento para el hipotiroidismo? ¿Puede la dieta ayudar con el hipotiroidismo? ¿Cuándo es el mejor momento del día para tomar su medicina de hipotiroidismo? ¿Dónde puede encontrar un médico para tratar el hipotiroidismo? Dra. Sandra Daniela Licht de Hospital General de consultorio particular y en INEBA ( Instituto de Neurociencias de Buenos Aires) Endocrinologia ESPECIALIDAD Establecimiento: General de Agudos J. M. Ramos Mejía. Título: Clinica Medica. Establecimiento: Hospital General de Agudos Carlos G.
Durand. Titulo: Endocrinologia ACTIVIDAD ACADEMICA Y DOCENTE Instructora de Residentes de Endocrinología, Htal Durand (1993-1995) Docente de la Diplomatura en Enfermedades Tiroideas de la Facultad de Medicina de la Universidad Nacional de Tucumán SOCIEDADES CIENTIFICAS • Miembro Titular, Sociedad Argentina de Endocrinología y Metabolismo. • Miembro Titular, Sociedad Latinoamericana de Tiroides. • Miembro Titular, The Endocrine Society. • Miembro Titular, American Thyroid Asociation. • Miembro del Comité de Asuntos Internacionales, The Endocrine Society (2005-2006). • Miembro del Comité Hormone Foundation, The Endocrine Society (2007-2010). • Miembro del Comité Patient Education and Advocacy Committee, American Thyroid Association (2008). • Miembro del Comité Clinical Affaires, American Thyroid Association. • Miembro del Comité Working Group on Disparities in Clinical Trials, The Endocrine Society. • Miembro del Comité de Publicaciones, The Endocrine Society. • Miembro del Comité Clinical Guidelines, The Endocrine Society. • Asesora médica de ACTIRA. • Asociación de Pacientes con Cáncer de Tiroides de la República Argentina. • Miembro del Medical Advisory Panel of Thyroid Cancer Alliance (desde el año 2011). Asociación Americana de la Tiroides - Español

7 Apr 201718min